Clinical Trials in San Antonio

Showing 6341-6360 of 14,633 trials

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

NCT05664100

This single-blind, placebo-controlled trial will be conducted to evaluate the safety of FX-345 administered as a single intratympanic injection in adults with acquired sensorineural hearing loss. The primary objectives are to assess the local safety, systemic safety, and pharmacokinetic (PK) profile to determine systemic exposure.

Hearing Loss, Sensorineural

Frequency Therapeutics6 participantsStarted Dec 2022

Sarasota, Florida, United States • Spartanburg, South Carolina, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPhase 2< 1 mile

FX-322 in Adults With Stable Sensorineural Hearing Loss

NCT04120116

This is a phase 2a single and repeat dose exploratory efficacy study of intratympanic FX-322 compared to placebo in healthy male and female adults with stable sensorineural hearing loss.

Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss

Frequency Therapeutics95 participantsStarted Oct 2019

Fresno, California, United States • Torrance, California, United States • Colorado Springs, Colorado, United States +13 more locations

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

FX-322 in Adults With Stable Sensorineural Hearing Loss

Find Trials by Condition in San Antonio

Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors

mHealth for Patient Self-Management of Opioid Use Disorder

Randomized Trial in Adult Participants With Acute Migraines

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery

Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Relative Bioavailability of LY03010 Compared to Listed Drug

A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

Rapid Diagnostics for HIV and Hepatitis

A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.